Stock listing
HALO Stock Price, News, Filings & Events — Halozyme Therapeutics, Inc.
Selected listing: HALO · NASDAQ · USD · US
This page tracks Halozyme Therapeutics, Inc.'s HALO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HALO:NASDAQ. HALO:NASDAQ is the stock-level entry point for investors researching Halozyme Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Halozyme Therapeutics, Inc. is a public company listed under the ticker HALO, operating in the American market. With a market capitalization of approximately $9.72 billion, Halozyme focuses on developing and commercializing innovative therapies for various medical conditions. The company is known for its proprietary enzyme technology that enhances the delivery of biologic therapies.
- Ticker
- HALO:NASDAQ
- Asset type
- Stock
- Market cap
- $11.96B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Halozyme Therapeutics, Inc. HALO:NASDAQ stock context
This page tracks Halozyme Therapeutics, Inc.'s HALO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HALO:NASDAQ. HALO:NASDAQ is the stock-level entry point for investors researching Halozyme Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Halozyme Therapeutics, Inc. is a public company listed under the ticker HALO, operating in the American market. With a market capitalization of approximately $9.72 billion, Halozyme focuses on developing and commercializing innovative therapies for various medical conditions. The company is known for its proprietary enzyme technology that enhances the delivery of biologic therapies.
Latest news from Halozyme Therapeutics, Inc.
Halozyme Appoints Dannielle Appelhans to its Board of Directors
August 18, 2026
Halozyme to Report Second Quarter 2026 Financial and Operating Results
July 23, 2026
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA...
July 21, 2026
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA...
July 20, 2026
Halozyme Appoints David Ramsay as President Drug Delivery
June 30, 2026
Halozyme Therapeutics, Inc. earnings calls
Halozyme Therapeutics, Inc. (HALO) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call
May 11, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q4 2025 Earnings Call
January 28, 2026 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q3 2025 Earnings Call
November 3, 2025 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Halozyme Therapeutics, Inc. (HALO) Q1 2025 Earnings Call
May 6, 2025 · Replay with transcript and chapters
Research Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for HALO:NASDAQ.
Halozyme Therapeutics, Inc. company profile
View the public company page for Halozyme Therapeutics, Inc. on 6ix.
Halozyme Therapeutics, Inc. news
Read company news and market updates connected to Halozyme Therapeutics, Inc..
Halozyme Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Halozyme Therapeutics, Inc..
Alternate listings
RV7:GETTEX
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
RV7:TRADEGATE
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
A0DLHS:LSX
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
HALO:BOATS
US · USD
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
RV7:FWB
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
A0DLHS:LS
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
HALO:BMV
MX · MXN
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
0J2O:LSE
GB · USD
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
1HALO:MIL
IT · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
HALO:BIVA
MX · MXN
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
RV7:BX
CH · CHF
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.
RV7:DUS
DE · EUR
Alternate listing for Halozyme Therapeutics, Inc.; the primary context on this page is HALO:NASDAQ.